At Apellis, our values are the roadmap for our people and our leadership, guiding every step, every decision, and every action we take.?Learn more about our culture at https://lnkd.in/ezckD-Ns. #WeAreApellis
Apellis Pharmaceuticals
生物技术研究
Waltham，MA 71,722 位关注者
Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
关于我们
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: https://bit.ly/476Q8
- 网站
-
https://apellis.com/
Apellis Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Waltham，MA
- 类型
- 上市公司
- 创立
- 2008
- 领域
- Targeted C3 Therapies、Complement System、Hematology、Ophthalmology、Nephrology、Paroxysmal Nocturnal Hemoglobinuria (PNH)、Geographic Atrophy (GA)、C3 Glomerulopathy (C3G)、Cold Agglutinin Disease (CAD)、Gene Therapy、Neurology和Amyotrophic Lateral Sclerosis (ALS)
地点
Apellis Pharmaceuticals员工
-
Beth Marsh
Commercial Strategy and Launch | Sales Management | Business Development | Training & Development
-
Alexandre de Jesus
Associate Director @ Apellis Pharmaceuticals | Commercial Operations Excellence
-
Renaud Desgraz, PhD
-
Lisa Paul-Stark
Patient focused rare disease medical sales professional with over 20 years of success, including more than 18 years in rare/Orphan disease, focusing…
动态
-
One of humankind’s greatest fears is permanent vision loss. That’s why we are fearless in the fight against vision loss and committed to moving the field forward for patients like Santi. Learn more about our work in #GeographicAtrophy in celebration of #WorldRetinaDay: https://lnkd.in/ep2XRr5q #WeAreApellis
-
-
Today, we shared an update on the review of our investigational treatment for geographic atrophy in the European Union. Learn more: bit.ly/3NdilI9
-
-
This year, #PNHAwarenessWeek focuses on purpose, people and progress. At Apellis, we're proud to support people living with and caring for those with PNH, this week and every week. What is #PNH or #ParoxysmalNocturnalHemoglobinuria? Get the facts, hear engaging stories, and access a range of resources at https://thisispnh.com/.? #WeAreApellis
-
-
Will you be at #EURETINA2024 next week? Join us along with a panel of leading experts in retina as they discuss #GeographicAtrophy (GA) and lead an interactive case discussion. You won’t want to miss it! #WeAreApellis
-
-
#TeamApellis in Australia was proud to support the launch of the report, "Geographic Atrophy, We Can’t Wait and See: The Case for Action," at Parliament House in Canberra yesterday. The report details recommendations for the management of #GeographicAtrophy (GA), a debilitating condition that leads to irreversible vision loss, impacting over 75,000 Australians. Thank you to the advisory committee, Vision 2020 Australia, Vision Australia, Retina Australia, Optometry Australia, Macular Disease Foundation Australia and Sight For All for providing six critical recommendations that can lead to improved outcomes for people living with GA if action is taken! #GAwecantwaitandsee
-
-
Hello, Portugal! ?? We're thrilled to be at The Retina Society Annual Meeting to discuss the latest developments in #GeographicAtrophy (GA). #WeAreApellis
-
-
Early and ongoing discussions with patients living with #GeographicAtrophy (GA) can help manage both the physical and emotional outcomes of the condition. Learn more about our work in GA at https://bit.ly/44kDPcb *Geographic Atrophy Insights Survey (GAINS) (N=203) was conducted by The Harris Poll and sponsored by Apellis Pharmaceuticals
-
-
It’s no secret that #WeLoveWhatWeDo at Apellis. We are passionate about our work, our purpose, and the positive impact we can make. Learn more about our culture:?https://lnkd.in/ezckD-Ns #WeAreApellis
-
We're inspired every day by the rare disease community. Hear from Ashley about how living with a rare disease like #PNH has changed her outlook on life. #WeAreApellis